The Duchenne muscular dystrophy therapeutics industry grows at 13.2% CAGR to US$6.64 billion by 2033, propelled by cell therapies and partnerships. Learn about Europe’s 34.5% share, subcutaneous options' potential, and global shifts toward accessible treatments for rare genetic disorders. https://finance.yahoo.com/news/duchenne-muscular-dystrophy-therapeutics-market-083800204.html